Viakos Pharmaceuticals Private Limited, a active private limited company, was established on 05 September 2020 in Mumbai, Maharashtra, India. Engaging in drug formulation & development within the trade sector, it holds CIN: U24304MH2020PTC345429. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹2.50 M and a paid-up capital of ₹0.10 M.
It upholds a compliant status. Employing 3 professional, Its leadership includes Prabhjot Sahani (Additional Director), Hemant Ghanshyam Gupta (Member). Past directors included Alisha Akhtar Hussain, Deepika Vikas Chavan. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Shop E-25 Devshrushthi Complex Bldg-1 Vasai Palghar Vasai-Virar City (M Corp), Mumbai, Maharashtra, 401203.
U24304MH2020PTC345429
345429
05 September 2020
₹2.50 M
₹0.10 M
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Viakos Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Prabhjot Sahani | Additional Director | 16 Jun 2023 | Current |
| Hemant Ghanshyam Gupta | Member | 26 May 2022 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 01 Jul 2022 | Past |
| Pramod Abcsdd | Nominee | 24 May 2022 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Viakos Pharmaceuticals Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 14.12% decrease. The company also saw a substantial improvement in profitability, with a 12.39% increase in profit. The company's net worth moved up by a moderate rise of 7.81%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
Unlock access to Viakos Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Viakos Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Viakos Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Viakos Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Viakos Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was recorded as a recent event.
Progress on Viakos Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai. was documented.
Progress on Prabhjot Sahani was appointed as a Additional Director was appointed as a Additional Director on 16 Jun 2023 & has been associated with this company since 2 years 6 months . was documented.
The activity Hemant Ghanshyam Gupta was appointed as a Member was appointed as a Member on 26 May 2022 & has been associated with this company since 3 years 6 months . was completed.
The activity Viakos Pharmaceuticals Private Limited was registered on 05 Sep 2020 with Roc Mumbai & aged 5 years 3 months as per MCA records. was completed.
The CIN of Viakos Pharmaceuticals Private Limited is U24304MH2020PTC345429.
Viakos Pharmaceuticals Private Limited is headquartered at Shop E-25 Devshrushthi Complex Bldg-1 Vasai Palghar Vasai-Virar City (M Corp), Mumbai, Maharashtra, 401203.
Viakos Pharmaceuticals Private Limited was incorporated on 05 September 2020.
The current directors of Viakos Pharmaceuticals Private Limited are
The primary industry of Viakos Pharmaceuticals Private Limited is Trade.
Viakos Pharmaceuticals Private Limited is unlisted.
The authorized capital of Viakos Pharmaceuticals Private Limited is ₹2.50 M, and the paid-up capital is ₹0.10 M.
The compliance status of Viakos Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX